Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis
NCT00759148
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1179
Enrollment
INDUSTRY
Sponsor class
Conditions
Bacterial Conjunctivitis
Interventions
DRUG:
Moxifloxacin Alternative Formulation (AF) Ophthalmic Solution 0.5%
OTHER:
Moxifloxacin AF Vehicle
Sponsor
Alcon Research